Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
With the rapid pace and scale of the emerging coronavirus 2019 (COVID-19) pandemic, a growing body of evidence has shown a strong association of COVID-19 with pre- and post- neurological complications. This has necessitated the need to incorporate targeted neurological care for this subgroup of patients which warrants further reorganization of services, healthcare workforce, and ongoing management of chronic neurological cases. The social distancing and the shutdown imposed by several nations in the midst of COVID-19 have severely impacted the ongoing care, access and support of patients with chronic neurological conditions such as Multiple Sclerosis, Epilepsy, Neuromuscular Disorders, Migraine, Dementia, and Parkinson disease. There is a pressing need for governing bodies including national and international professional associations, health ministries and health institutions to harmonize policies, guidelines, and recommendations relating to the management of chronic neurological conditions. These harmonized guidelines should ensure patient continuity across the spectrum of hospital and community care including the well-being, safety, and mental health of the patients, their care partners and the health professionals involved. This article provides an in-depth analysis of the impact of COVID-19 on chronic neurological conditions and specific recommendations to minimize the potential harm to those at high risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668 · cited 2×
“6 and 88% of patients, respectively (10).”
BackgroundRogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30203-0 · Cited by 2,407
Li, Y., Bai, W., & Hashikawa, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25728 · Cited by 2,266 · cited 1×
“Studies investigating the neurovirological manifestations of COVID-19 are being conducted increasingly, as growing evidence demonstrates the ability of the virus to cross the blood-brain barrier and due to involvement of angiotensinconverting enzyme 2 (ACE2) receptor (77).”
BackgroundCOVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features
Poyiadji, N., Shahin, G., Noujaim, D., Stone, M., Patel, S., & Griffith, B. (2020) · Radiology · doi:10.1148/radiol.2020201187 · Cited by 1,505
Brann, D. H., Tsukahara, T., Weinreb, C., Lipovsek, M., Van den Berge, K., Gong, B., Chance, R., Macaulay, I. C., Chou, H.-J., Fletcher, R. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc5801 · Cited by 1,198
Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2065 · Cited by 923
Wang, H., Li, T., Barbarino, P., Gauthier, S., Brodaty, H., Molinuevo, J. L., Xie, H., Sun, Y., Yu, E., Tang, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30755-8 · Cited by 562 · cited 3×
“The Alzheimer’s Disease International and international dementia expert panel has called for an urgent need of mental health and psychosocial support, in addition to physical protection from COVID-19 infection, for people living with dementia and their carers (84).”
Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients
Lee, Y., Min, P., Lee, S., & Kim, S.-W. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e174 · Cited by 528 · cited 1×
“7% in the early stage of COVID-19 and in patients with asymptomatic-to-mild disease severity, respectively (11).”
BackgroundCOVID-19: ICU delirium management during SARS-CoV-2 pandemic
Kotfis, K., Williams Roberson, S., Wilson, J. E., Dabrowski, W., Pun, B. T., & Ely, E. W. (2020) · Critical Care · doi:10.1186/s13054-020-02882-x · Cited by 506
Cited by
Bhaskar, S., Sinha, A., Banach, M., Mittoo, S., Weissert, R., Kass, J. S., Rajagopal, S., Pai, A. R., & Kutty, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01648 · Cited by 511
Self-citationBhaskar, S., Bradley, S., Chattu, V. K., Adisesh, A., Nurtazina, A., Kyrykbayeva, S., Sakhamuri, S., Yaya, S., Sunil, T., Thomas, P., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.556720 · Cited by 305
“The framework developed by the MoHFW included five scenarios (32): (1) Patient to Registered Medical Practitioner; (2) Caregiver to Registered Medical Practitioner; (3) Health Worker to Registered Medical Practitioner; (4) Registered Medical Practitioner to Registered Medical Practitioner (31) and (5) Emergency Situat…”
MethodSelf-citationImpact of COVID-19 on people with physical disabilities: A rapid review
Lebrasseur, A., Fortin-Bédard, N., Lettre, J., Bussières, E.-L., Best, K., Boucher, N., Hotton, M., Beaulieu-Bonneau, S., Mercier, C., Lamontagne, M.-E., et al. (2021) · Disability and Health Journal · doi:10.1016/j.dhjo.2020.101014 · Cited by 262
Designing Futuristic Telemedicine Using Artificial Intelligence and Robotics in the COVID-19 Era
Bhaskar, S., Bradley, S., Sakhamuri, S., Moguilner, S., Chattu, V. K., Pandya, S., Schroeder, S., Ray, D., & Banach, M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.556789 · Cited by 137
Self-citationSharma, R., Singla, R. K., Banerjee, S., Sinha, B., Shen, B., & Sharma, R. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104795 · Cited by 81
Metadata
- Authors
- Bhaskar, S., Bradley, S., Israeli-Korn, S., Menon, B., Chattu, V. K., Thomas, P., Chawla, J., Kumar, R., Prandi, P., Ray, D., Golla, S., Surya, N., Yang, H., Martinez, S., Ozgen, M. H., Codrington, J., González, E. M. J., Toosi, M., Hariya Mohan, N., Menon, K. V., Chahidi, A., & Mederer Hengstl, S.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-24
- Volume
- 11
- Pages
- 664-664
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W3038055921
- Cited by
- 91
- References
- 12
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium. https://app.cochat.ai/papers/10.3389/fneur.2020.00664
- The paper
- Bhaskar, S., Bradley, S., Israeli-Korn, S., Menon, B., Chattu, V. K., Thomas, P., Chawla, J., Kumar, R., Prandi, P., Ray, D., Golla, S., Surya, N., Yang, H., Martinez, S., Ozgen, M. H., Codrington, J., González, E. M. J., Toosi, M., Hariya Mohan, N., . . . Mederer Hengstl, S. (2020). Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium. Frontiers in Neurology. https://doi.org/10.3389/fneur.2020.00664
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.